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Dendritic cells (DCs) are targets ofmeasles virus (MV)
and play central roles in viral dissemination. How-
ever, DCs express the RIG-I-like receptors (RLRs)
RIG-I and Mda5 that sense MV and induce type I
interferon (IFN) production. Given the potency of
this antiviral response, RLRs are tightly regulated at
various steps, including dephosphorylation by PP1
phosphatases, which induces their activation. We
demonstrate that MV suppresses RIG-I and Mda5
by activating the C-type lectin DC-SIGN and inducing
signaling that prevents RLR dephosphorylation. MV
binding to DC-SIGN leads to activation of the kinase
Raf-1, which induces the association of PP1 inhibitor
I-1 with GADD34-PP1 holoenzymes, thereby inhibit-
ing phosphatase activity. Consequently, GADD34-
PP1 holoenzymes are unable to dephosphorylate
RIG-I and Mda5, hence suppressing type I IFN re-
sponses and enhancing MV replication. Blocking
DC-SIGN signaling allows RLR activation and sup-
presses MV infection of DCs. Thus, MV subverts
DC-SIGN to control RLR activation and escape anti-
viral responses.
INTRODUCTION
Measles is a highly contagious airborne disease and remains a
major cause of morbidity and mortality despite the availability of
an effective vaccine (WHO, 2012). The causative agent, mea-
sles virus (MV), severely suppresses immune responses in the
host, leading to secondary opportunistic infections (Moss and
Griffin, 2012). Production of antiviral type I interferon (IFN) is
important for the control of MV replication and hence disease
progression. Therefore, MV has evolved various strategies to
suppress type I IFN responses, most of which rely on the non-
strucural MV-V protein that can antagonize activation of patternCrecognition receptors (PRRs) or signaling upstream of type I
IFN responses (Fontana et al., 2008; Goodbourn and Randall,
2009).
Type I IFN responses induced by single-stranded RNA
(ssRNA) viruses, such as MV, are mediated by the cytoplasmic
RIG-I-like receptors (RLRs) RIG-I and Mda5. RIG-I interacts
with the 50 leader of MV ssRNA to induce IFN-b (Plumet
et al., 2007). The mechanisms leading to Mda5 activation by
MV are still unknown (Ikegame et al., 2010). RLR triggering
leads to activation of IkB kinase (IKK)-related kinases, IKKε
and Tank-binding protein (TBK1), through the mitochondrial
antiviral signaling (MAVS; also known as IPS-1) adaptor protein
(Fitzgerald et al., 2003; Sharma et al., 2003). Both IKKε and
TBK1 activate transcription factor IRF3, which induces expres-
sion of IFN-b (Kawai and Akira, 2008). Signaling by IFN-b via
type I IFN-a/b receptor (IFNAR) on infected and neighboring
cells induces transcription of hundreds of interferon-stimulated
genes (ISGs), such as MxA and ISG15, that are paramount in
defense against viruses (Fontana et al., 2008). RLR signaling
pathways induce a very potent and rapid type I IFN response;
therefore, activation of RLRs is tightly regulated by multiple
consecutive processes, including dephosphorylation, ubiquiti-
nation, and oligomerization of the RLR CARD domains (Gack
et al., 2007, 2010; Jiang et al., 2012; Nistal-Villa´n et al., 2010;
Wies et al., 2013; Zeng et al., 2010). Constitutive phosphoryla-
tion of CARD domain residues Ser8 and Thr170 of RIG-I and
Ser88 of Mda5 keeps RLRs inactive (Gack et al., 2010; Nis-
tal-Villa´n et al., 2010; Wies et al., 2013). RLR-induced type I
IFN production requires RLR dephosphorylation by serine-
threonine phosphatases PP1a and PP1g (Wies et al., 2013).
The exact regulation of these phosphatases is not yet under-
stood, but dephosphorylation of RIG-I and Mda5 is crucial
for activation of MAVS and subsequent downstream signaling,
possibly through induction of oligomerization (Gack et al., 2010;
Nistal-Villa´n et al., 2010; Wallach and Kovalenko, 2013; Wies
et al., 2013).
Airborne infection of MV initiates in the lungs and disseminates
to lymphocytes throughout the host within 2 weeks postinfection
(de Swart et al., 2007; Lemon et al., 2011). DC-SIGN+ dendritic
cells (DCs) in the lungs are among the first cells that becomeell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc. 31
Figure 1. MV Infection of DCs Is Dependent on CD150, while DC-SIGN Enhances Infection and Replication
(A and B) Infection and replication in DCs 24 hr after infection with rMVKSEGFP(3) in the absence or presence of blocking DC-SIGN or CD150 antibodies,
determined by flow cytometry by measuring the percentage or mean fluorescence intensity (MFI) of EGFP+ cells. Data are presented as mean ± SD of duplicate
samples.
(C) MV-NmRNA expression by DCs 0, 2, 6, and 8 hr after infection with rMVKS, measured by real-time PCR, normalized to GAPDH, and set at 1 in 2 hr MV-infected
cells. Data are presented as mean ± SD.
Data are representative of at least three (A and B) or two (C) independent experiments.
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signaling lymphocyte activation molecule (SLAM, CD150), the
entry receptor for wild-type MV (de Swart et al., 2007; Tatsuo
et al., 2000). Interaction of MV with C-type lectin receptor
DC-SIGN enhances infection of DCs and subsequent viral trans-
mission to lymphocytes (de Witte et al., 2006, 2008; Mesman
et al., 2012). DCs also induce MV-specific adaptive immunity;
DC-SIGN sensing of MV induces innate signaling mediated by
serine-threonine kinase Raf-1, which modulates Toll-like recep-
tor (TLR)-induced immune responses (Gringhuis et al., 2007).
Raf-1 signaling induces phosphorylation and acetylation of
TLR-induced NF-kB subunit p65, thereby increasing expression
of proinflammatory cytokines affecting immune responses
(Gringhuis et al., 2007, 2009a). However, little is known about
the role of innate signaling induced by MV on type I IFN re-
sponses in DCs.
Here, we show that MV efficiently infects primary human
DCs by inhibiting RLR-induced type I IFN responses. We
demonstrate that GADD34 is the regulatory subunit of the PP1
phosphatases that activate both RIG-I and Mda5, while activity
of GADD34-PP1 holoenzymes is regulated by PP1 inhibitor 1
(I-1). Notably, MV binding to DC-SIGN at the cell surface pre-
vents dephosphorylation of both RIG-I and Mda5 by inhibiting
GADD34-PP1 holoenzyme activation via Raf-1 signaling. Raf-1
activation induces phosphorylation of I-1, thereby inducing
complex formation between I-1 and GADD34-PP1 holoen-
zymes, which inhibits its phosphatase activity. Inhibition of
dephosphorylation of both RIG-I and Mda5 suppresses type I
IFN responses in DCs upon MV infection. Interference with
DC-SIGN signaling allows dephosphorylation of both RLRs,
leading to strong antiviral type I IFN responses that suppress
MV replication. Triggering of innate signaling by MV to circum-
vent cellular antiviral mechanisms precedes viral evasion tactics
that rely on viral replication and de novo synthesis of viral pro-
teins, hence acting earlier during infection. Thus, we have un-
covered a regulatory mechanism that controls RLR activation
and identified the phosphatase inhibitor I-1 as a target for
suppression of antiviral responses, which is exploited by MV
to infect DCs. This evasion mechanism might be used by
other viruses and targeted therapeutically for more efficient
combating of viral infections.32 Cell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc.RESULTS
MV Infection of DCs Requires Both CD150 and DC-SIGN
To investigate the function of viral receptors involved in replica-
tion of MV, human monocyte-derived DCs were infected with
pathogenic strain rMVKSEGFP(3) (rMVKS) in the presence of
blocking antibodies against CD150 and DC-SIGN. This virulent
recombinant strain expresses enhanced GFP (EGFP) as a result
of viral replication, without altering its pathogenicity (de Swart
et al., 2007; de Vries et al., 2012; Lemon et al., 2011; Ludlow
et al., 2013). DCs were efficiently infected with the virus as
measured by flow cytometry 24 hr postinfection (h.p.i.). CD150
was crucial for infection since blocking antibodies against
CD150 almost completely abrogated infection, whereas block-
ing DC-SIGN binding decreased infection (Figure 1A). Analysis
of GFP expression in infected cells, as a measure for replication,
showed that CD150 blocking antibodies did not alter the replica-
tion level of MV in DCs, despite the large effect on the percent of
infected cells (Figure 1B). Notably, blocking DC-SIGN binding
decreased MV infection as well as replication in DCs (Figures
1A and 1B), suggesting that DC-SIGN signaling affects not
only fusion but also the replication cycle of MV. We next deter-
mined viral transcription over time after infection of DCs. MV-N
is the first transcribed gene of the unsegmented MV genome
upon cellular entry (Rima and Duprex, 2009). We detected MV-
N mRNA as early as 2 h.p.i., accumulating over time, while viral
transcription was strongly decreased with blocking antibodies
against both CD150 and DC-SIGN (Figure 1C). These data indi-
cate that both CD150 and DC-SIGN are important for early tran-
scription; however, whereas CD150 is required for infection, MV
binding to DC-SIGN is critical for both infection and replication.
RIG-I and Mda5 Mediate Type I IFN Responses to MV
in DCs
Since type I IFN responses affect viral replication (Fontana et al.,
2008), we examined IFN-b expression as well as functional type I
IFN responses by measuring induction of antiviral ISGs, such as
MxA, in DCs infected with rMVKS. Infection of DCs with rMVKS
induced IFN-b as well as MxA expression (Figures 2A and 2B).
Viral transcription or replication of MV is required for induction
of type I IFN responses (Duhen et al., 2010). Blocking viral entry
Figure 2. MV-Induced Type I IFN Responses in DCs Are Dependent on RLR Signaling via TBK1 and IKKε
(A–C, E, and F) IFN-b, MxA, ISG15, RIG-I, and Mda5 mRNA expression by DCs at indicated times (A) or 24 hr after infection with rMVKS (B, C, and F), or 8 hr after
stimulation with poly(I:C)-LyoVec (poly(I:C)-LV) (E), in the absence or presence of blocking CD150 antibodies, fusion inhibitor protein (FIP), or neutralizing soluble
IFNAR (B18R) (B), or after silencing of RIG-I and/or Mda5 (C and E), or TBK1 and/or IKKε (F) by RNAi (siRNA), measured by real-time PCR, normalized to GAPDH,
and set at 1 in MV- or poly(I:C)-LV-stimulated (control-silenced) cells. Data are presented as mean ± SD. N.d., not determined; n.s., not statistically significant;
*p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test).
(D) Infection of DCs 24 hr after infection with rMVKS after silencing of RIG-I or Mda5, determined by flow cytometry by measuring the percentage of EGFP+ cells.
Data are presented as mean ± SD of duplicate samples.
Data are representative of at least four (A), three (B–E), or two (F) independent experiments. See also Figure S1.
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antibodies or fusion inhibitor protein (FIP) decreased mRNA
expression of IFN-b and ISGs MxA, ISG15, RIG-I, and Mda5
to steady-state levels (Figure 2B). Furthermore, MV-induced
expression of ISGs was inhibited by soluble IFNAR, which scav-
enges IFN and prevents IFN-induced signaling (Figure 2B).
Thus, MV infection induces type I IFN responses and enhances
expression of antiviral proteins, including the sensors RIG-I
and Mda5, in an IFNAR-dependent manner. We next studied
whether RIG-I and Mda5 mediate MV-induced type I IFN re-
sponses in DCs. Silencing of either RIG-I or Mda5 by RNAi (Fig-
ure S1, available online) decreased expression of IFN-b andMxA
in response to MV, whereas silencing of both receptors together
almost completely abolished IFN-b and MxA expression (Fig-
ure 2C). Notably, DC infection was enhanced when either RIG-I
or Mda5 was silenced (Figure 2D), strongly indicating that type
I IFN responses to MV limit MV replication. Transfection of DCs
with RLR ligand poly(I:C)-LyoVec (poly(I:C)-LV) induced type I
IFN responses, which were abrogated by silencing of either re-Cceptor (Figure 2E), supporting specificity of RLR silencing. RLR
signaling through adaptor protein MAVS induces activation of
TBK1 and IKKε through phosphorylation at specific sites (Fitz-
gerald et al., 2003; Sharma et al., 2003). Silencing of either
TBK1 or IKKε (Figure S1) reduced MV-induced IFN-b, MxA,
and ISG15 expression, whereas combined silencing of TBK1
and IKKε almost completely abrogated MV-induced type I IFN
responses in DCs (Figure 2F). These data demonstrate that
MV-induced antiviral type I IFN responses in DCs are triggered
via both RIG-I and Mda5 and depend on TBK1-IKKε signaling.
MV Suppresses Type I IFN Responses via DC-SIGN
Efficient infection of DCs with MV suggests that MV escapes
antiviral type I IFN responses. Since MV interacts with DC-
SIGN, and this interaction was crucial for MV replication (Fig-
ure 1), we next investigated whether DC-SIGN signaling affects
RLR-induced type I IFN responses. Transfection of DCs with
poly(I:C)-LV led to induction of type I IFN responses, which,
notably, were strongly impaired by DC-SIGN triggering viaell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc. 33
Figure 3. Raf-1 Activation via DC-SIGN Decreases MV-Induced Type I IFN Expression
(A and C) IFN-b, MxA, and ISG15 mRNA expression by DCs 8 hr after stimulation with poly(I:C)-LV and/or receptor crosslinking with isotype or DC-SIGN-
specific antibodies (A), in the absence or presence of Raf inhibitor GW5074 (A) or after Raf-1 silencing (C), measured by real-time PCR, normalized to GAPDH,
and set at 1 in poly(I:C)-LV-stimulated (control-silenced) cells. Data are presented as mean ± SD. N.s., not statistically significant; *p < 0.05; **p < 0.01
(Student’s t test).
(B) Silencing of Raf-1 using specific SMARTpools and nontargeting siRNA as a control. Silencing was confirmed by real-time PCR (left) or flow cytometry (right; FI,
fluorescence intensity). During real-time PCR analysis, mRNA expression was normalized to GAPDH and set at 1 in control-silenced cells. Data (real-time PCR)
are presented as mean ± SD.
(D and E) Raf-1 phosphorylation at Ser338 or Tyr340–Tyr341 in DCs left unstimulated (dashed line) or 15min after stimulation by receptor crosslinking with isotype
(black line) or DC-SIGN-specific (filled) antibodies (D), or rMVKS infection in the absence (black line) or presence (filled) of blocking DC-SIGN antibodies (E).
(F and G) IFN-b, MxA, and ISG15mRNA expression by DCs 24 hr after infection with rMVKS, in the absence or presence of Raf inhibitor GW5074 (F) or after Raf-1
silencing (G), measured by real-time PCR, normalized to GAPDH, and set at 1 in MV-stimulated (control-silenced) cells. Data are presented as mean ± SD. N.s.,
not statistically significant; *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test).
Data are representative of at least three independent experiments. See also Figure S3.
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SIGN-mediated suppression of RLR-induced type I IFN re-
sponses was dependent on Raf-1 signaling (Gringhuis et al.,
2007), we blocked Raf-1 activity via small molecule inhibitor
GW5074 (Lackey et al., 2000) or Raf-1 silencing (Figure 3B).
Blocking Raf-1 signaling reversed DC-SIGN-mediated suppres-
sion of poly(I:C)-LV-induced IFN-b, MxA, and ISG15 mRNA
expression (Figures 3A and 3C). Thus, DC-SIGN signaling sup-
presses RLR-induced type I IFN responses via Raf-1 activation.
DC-SIGN triggering with various pathogen ligands activates
Raf-1 through phosphorylation of Ser338 and Tyr340–Tyr34134 Cell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc.(Gringhuis et al., 2007, 2009a). Similarly, crosslinking of DC-
SIGN with specific DC-SIGN antibodies, in contrast to isotype
controls, led to Raf-1 phosphorylation at both Ser338 and
Tyr340–Tyr341 (Figure 3D). Notably, DC infection with rMVKS
also led to phosphorylation of Raf-1, in a DC-SIGN-dependent
manner (Figure 3E). We next investigated whether Raf-1
signaling via DC-SIGN is involved in MV-mediated suppression
of type I IFN responses. Notably, inhibition of Raf-1 by either
GW5074 or Raf-1 silencing increased MV-mediated IFN-b,
MxA, and ISG15 expression in response to infection with rMVKS
(Figures 3F and 3G). These data demonstrate that DC-SIGN
Figure 4. DC-SIGN-Raf-1 Signaling Inhibits Dephosphorylation of RIG-I and Mda5
(A–D) RIG-I phosphorylation at Ser8 or Thr170 andMda5 phosphorylation at Ser88 in DCs left unstimulated; or 3 hr after stimulation by crosslinkingwith isotype or
DC-SIGN-specific antibodies (A and B), in the absence or presence of Raf inhibitor GW5074 (B); or 8 or 16 hr after rMVKS infection or 3 hr after or rMVIC323EGFP(1)
in the absence or presence of Raf-1 inhibition via GW5074 (C) or Raf-1 silencing (D), as determined by flow cytometry.
Data are representative of at least four (A–C; rMVIC323, 8 hr rMVKS), two (C; 16 hr rMVKS), or three (D) independent experiments. See also Figure S2.
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Raf-1, while MV uses this mechanism to impair type I IFN pro-
duction in DCs.
DC-SIGN Signaling via Raf-1 Suppresses RLR Activation
Constitutive phosphorylation of the CARD domains of RIG-I and
Mda5 keeps the receptors in their inactive state. Therefore, acti-
vation requires dephosphorylation of RIG-I at Ser8 and Thr170,
and Mda5 at Ser88 (Gack et al., 2010; Nistal-Villa´n et al., 2010;
Wies et al., 2013). We next investigated whether DC-SIGN/Raf-
1 signaling affects phosphorylation of RIG-I and Mda5. First,
we observed that DC-SIGN crosslinking prevented poly(I:C)-
LV-induced dephosphorylation of RIG-I and Mda5 (Figure 4A).
Moreover, Raf-1 inhibition restored dephosphorylation of
both receptors (Figure 4B). These data indicate that DC-SIGN
signaling suppresses RLR activation via Raf-1 by preventing
dephosphorylation of their CARD domains. Strikingly, infection
with rMVKS did not result in dephosphorylation of RIG-I and
Mda5 at 8 h.p.i., whereas inhibition or silencing of Raf-1 dramat-
ically increased the MV-induced dephosphorylation of both re-
ceptors (Figures 4C, 4D, and S2). Similarly, dephosphorylation
of RIG-I and Mda5 was blocked in a Raf-1-dependent mannerCafter infection of DCs with another pathogenic MV strain,
rMVIC323EGFP(1) (rMVIC323) (de Swart et al., 2007), that also
required DC-SIGN for infection and replication (Figures 4C, 4D,
and S3). These data show that MV-induced Raf-1 signaling sup-
presses RIG-I and Mda5 activation by preventing dephosphory-
lation. Notably, at 16 h.p.i., rMVKS induced dephosphorylation of
RIG-I at Ser8 and Thr170, but not Mda5 at Ser88 (Figure 4C),
which could explain the increase in IFN-b and MxA levels be-
tween 8 and 24 h.p.i. (Figure 2A). Raf-1 inhibition did not restore
Mda5 dephosphorylation 16 hr after MV infection (Figure 4C),
suggesting that, late during infection, Mda5 dephosphorylation
is antagonized via another DC-SIGN-independent mechanism
(Davis et al., 2014). We next investigated the effect of DC-
SIGN triggering on downstream RLR signaling. We observed
that phosphorylation of TBK1 and IKKε at Ser172 in response
to poly(I:C)-LV stimulation was impaired by simultaneous DC-
SIGN triggering but was restored after Raf-1 inhibition (Fig-
ure 5A). Moreover, infection of DCs with either rMVKS or rMVIC323
induced a small increase in TBK1 and IKKε phosphorylation at
Ser172, which was strongly enhanced after inhibition of Raf-1
signaling (Figure 5B). Activation of TBK1 and IKKε precedes
phosphorylation and nuclear translocation of IRF3, whichell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc. 35
Figure 5. DC-SIGN-Raf-1 Signaling Attenuates RLR-Induced TBK1 and IKKε Phosphorylation and IRF3 Nuclear Translocation
(A and B) TBK1 and IKKε phosphorylation at Ser172 in DCs left unstimulated; or 3 hr after stimulation by receptor crosslinking with isotype or DC-SIGN-specific
antibodies, in the absence or presence of Raf inhibitor GW5074 (A); or 8 hr after rMVKS infection or 3 hr after or rMVIC323 in the absence or presence of Raf inhibitor
GW5074 (B), as determined by flow cytometry.
(C and D) IRF3 nuclear translocation in DCs 8 hr after rMVKS infection, in the absence or presence of GW5074, determined by ELISA in nuclear extracts (C) or
immunoblotting (IB) of nuclear and cytoplasmic extracts (D). In (D), RNAPII and b-actin served as loading controls. Data in (C) are presented as mean ± SD. N.s.,
not statistically significant; *p < 0.05 (Student’s t test).
Data are representative of at least four (A), three (B), or two (C) independent experiments.
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observed that rMVKS infection led to minor nuclear accumulation
of IRF3, while, again, Raf-1 inhibition strongly increased nuclear
translocation of IRF3, allowing IFN-b production (Figures 5C and
5D). These results demonstrate that DC-SIGN-induced Raf-1
activation suppresses downstream RLR signaling by blocking
the dephosphorylation of both RIG-I and Mda5.
Raf-1 Activation Blocks PP1 Activity to Attenuate RLR
Activation
Dephosphorylation of the CARD domains of RIG-I and Mda5 is
mediated by PP1a/g phosphatases (Wies et al., 2013); however,
little is known about the regulation of PP1 phosphatase activity.
To investigate whether DC-SIGN signaling interferes with the ac-
tivity of these phosphatases, we measured PP1 phosphatase
activity in lysates of DCs stimulatedwith poly(I:C)-LV in combina-
tion with DC-SIGN crosslinking or after infection with MV.
Although DC-SIGN activation slightly decreased overall PP1 ac-
tivity, no statistical differences between unstimulated and stimu-
lated cells were observed (Figure 6A). PP1 phosphatases are
ubiquitously expressed in cells, and PP1 holoenzymes consist
of a catalytic and regulatory subunit, the latter of which deter-
mines substrate specificity (Cohen, 2002; Peti et al., 2013). To
specifically examine whether Raf-1 influences PP1a/g phospha-
tases, we set out to identify the regulatory subunit of the PP1 ho-
loenzymes that control the dephosphorylation of RLRs. One of
the possible PP1-binding partners, growth arrest and DNA dam-
age protein (GADD34), has been reported to be required for IFN-
b responses after viral infection in DCs (Clavarino et al., 2012).36 Cell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc.We therefore investigated whether GADD34 association with
the catalytic PP1a/g subunits is involved in dephosphorylation
of RIG-I and Mda5. Pretreatment of DCs with the specific
GADD34 inhibitor guanabenz (Tsaytler et al., 2011) blocked
dephosphorylation of RIG-I at Ser8 and Thr170 and Mda5 at
Ser88 in a concentration-dependent manner, indicative of the
involvement of GADD34 in RLR activation (Figure 6B). We next
assessed GADD34-PP1-specific activity in DCs following
pull down of GADD34 from whole-cell lysates after poly(I:C)-LV
stimulation or MV infection. We observed a strong increase
in PP1 activity after poly(I:C)-LV stimulation, which was blocked
by DC-SIGN triggering (Figure 6C). Inhibition of Raf-1 restored
PP1 activity after poly(I:C)-LV plus DC-SIGN costimulation
(Figure 6C). Notably, DC infection with either rMVKS or rMVIC323
did not induce GADD34-PP1 activity; however, inhibition of
Raf-1 resulted in a strong increase in phosphatase activity (Fig-
ure 6C). These results strongly indicate that Raf-1 activation
blocks PP1 activity in GADD34-PP1 complexes to prevent RLR
activation.
Activity of GADD34-PP1 complexes is specifically inhibited by
I-1; association of I-1 with GADD34-PP1 blocks interactions be-
tween the holoenzymes and their substrates (Aggen et al., 2000).
Since I-1 requires phosphorylation at Thr35 and Ser67 for the as-
sociation with GADD34-PP1 complexes (Connor et al., 2001;
Huang and Paudel, 2000), we examined whether Raf-1 modu-
lates PP1 activity—and subsequent RLR activity—by phosphor-
ylating I-1. First, we assessed phosphorylation of I-1 upon MV
infection. I-1 became phosphorylated at both Ser and Thr resi-
dues in response to rMVKS, which coincided with its association
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Measles Virus Suppression of RLR Activationwith both PP1a and PP1g holoenzymes, as both catalytic sub-
units immunoprecipitated together with I-1 (Figure 6D). Both
phosphorylation and association of I-1 with PP1a and PP1g
was dependent on Raf-1 activity (Figure 6D). Next, we measured
RLR phosphorylation levels in DCs after silencing I-1 (Figure S1).
Silencing of I-1 allowed dephosphorylation of both RIG-I and
Mda5 after MV infection (Figure 6E). Similarly, I-1 silencing after
costimulation with poly(I:C)-LV and DC-SIGN crosslinking al-
lowed complete dephosphorylation of both RLRs to the same
level as poly(I:C)-LV alone (Figure 6F). Together, these results
show that Raf-1 signaling leads to phosphorylation of I-1 and
subsequent association of I-1 with PP1 holoenzymes, which pre-
vents RLR dephosphorylation and subsequent RLR activation.
Moreover, silencing of GADD34 (Figure S1) completely abol-
ished RLR dephosphorylation after MV infection or poly(I:C)-
LV stimulation (Figures 6E and 6F), confirming the role of
GADD34-PP1 holoenzymes in mediating RLR dephosphoryla-
tion. We next investigated the functional effects of this signaling
pathway on type I IFN expression. GADD34 silencing sup-
pressed RLR-induced IFN-b and ISG induction after poly(I:C)-
LV stimulation (Figure 6G), whereas I-1 silencing completely
abrogated DC-SIGN-mediated suppression of IFN-b and ISG
mRNA expression (Figure 6G). Moreover, rMVKS-induced IFN-b
and ISG mRNA levels, which were reduced via Raf-1 signaling,
strongly increased after I-1 silencing (Figure 6H). Together,
these results indicate that DC-SIGN-induced Raf-1-mediated
signaling induces association of I-1 with GADD34-PP1 holoen-
zymes to block PP1 activity and, subsequently, RLR dephos-
phorylation and RLR-mediated type I IFN responses to MV.
MV-Induced Raf-1 Activation Enables DC Infection
We next investigated whether DC-SIGN-induced inhibition of
GADD34-PP1 holoenzyme activity was required for MV infection
by silencing the regulatory subunit of PP1, GADD34, and the PP1
inhibitor I-1. Infection of DCs by MV was strongly increased by
silencing of GADD34 (Figure 7A), suggesting that loss of type I
IFN responses after GADD34 silencing (Figure 6H) allows
efficient replication of MV in DCs. Notably, silencing of I-1, which
is crucial in MV-induced type I IFN suppression, strongly
decreased MV infection at both 24 and 48 hr after infection (Fig-
ure 7B). Similarly, silencing of Raf-1 strongly decreased infection
of MV in DCs (Figure 7C), which is in line with the observed
increase of type I IFN responses (Figures 3E and 3F). We next
examined whether MV infection of lung-resident DC-SIGN+
DCs isolated from cynomolgus macaques was similarly depen-
dent on Raf-1 activation. Inhibition of Raf-1 increased MV-medi-
ated IFN-b and MxA expression in response to infection with
rMVKS (Figure 7D), while replication was attenuated (Figure 7E).
These data demonstrate that inhibition of phosphatase activity
and subsequent activation of RIG-I and Mda5 is an important
mechanism for MV to escape antiviral responses. Furthermore,
our data suggest that viruses such as MV target DC-SIGN to
suppress type I IFN responses and thereby infect DCs.
DISCUSSION
Type I IFN responses are crucial in the elimination of viral infec-
tions, and therefore viruses have developed several strategies to
manipulate these antiviral responses to escape immune surveil-Clance. DC-SIGN+ DCs are targeted by MV early in infection
(Lemon et al., 2011; Mesman et al., 2012), which makes them
an important target for suppression of antiviral responses by
the virus. Here we have elucidated the mechanism by which
MV suppresses type I IFN responses in DCs early after infection,
and we have identified DC-SIGN as an important suppressor of
RLR activity. Although MV triggered type I IFN responses via
RIG-I and Mda5, MV-induced DC-SIGN signaling via Raf-1
dampened RLR-elicited type I IFN expression. Raf-1 activation
following DC-SIGN ligation resulted in phosphorylation of the
inhibitory subunit I-1 at both Ser and Thr residues, thereby
inducing association of I-1 to GADD34-PP1a/g phosphatases.
As a result, GADD34-PP1 holoenzymes were inhibited and un-
able to dephosphorylate the RIG-I and Mda5 CARD domains,
preventing signaling via MAVS to downstream effectors TBK1
and IKKε, IRF3, and subsequent type I IFN expression, hence
promoting DC infection. Activation of innate signaling by MV
to circumvent cellular antiviral mechanisms precedes other viral
evasion tactics that rely on viral replication. In vivo relevance of
this DC-SIGN mechanism was emphasized in lung DCs from
nonhuman primates.
MV has been shown to trigger both RIG-I andMda5 in cell lines
(Shingai et al., 2007), and here we show that MV triggers both
RIG-I and Mda5 upon infection of DCs; however, their activation
is counteracted by the interaction of MV with DC-SIGN, allowing
efficient infection of DCs. Strikingly, we found that MV infection
of DCs almost completely inhibited dephosphorylation of RIG-I
residues Ser8 and Thr170 and Mda5 residue Ser88. Dephos-
phorylation of RIG-I at these residues has recently been
described as one of the steps preventing unnecessary signal
transduction to MAVS following ligand binding, since it allows
accessibility to the CARD domains enabling MAVS interactions
(Kolakofsky et al., 2012). Dephosphorylation of these residues
by serine-threonine phosphatases PP1a and PP1g is therefore
a prerequisite for RLR activation (Gack et al., 2010; Nistal-Villa´n
et al., 2010; Wies et al., 2013). PP1 phosphatases are involved in
many cellular processes, and their localization and actions are
defined by specific regulatory and inhibitory subunits (Cohen,
2002; Peti et al., 2013). Here we demonstrated that GADD34 is
the regulatory subunit of PP1a/g holoenzymes that target RIG-I
and Mda5 for dephosphorylation, and consequently are crucial
for subsequent type I IFN induction. Moreover, GADD34-
PP1 complexes were specifically inhibited by I-1. Activity of
GADD34-PP1 holoenzymes limited MV replication in DCs by
inducing type I IFN expression. Identification of PP1a/g regula-
tory subunit GADD34 and its specific inhibitor I-1 in the activation
process of RIG-I and Mda5 in DCs further advances our knowl-
edge of RLR receptor regulation.
Besides cytosolic RLRs, MV also triggered DC-SIGN
signaling, leading to DC-SIGN-mediated Raf-1 activation. We
found that MV-induced Raf-1 activation inhibited dephosphory-
lation of both RIG-I and Mda5, and thereby prevented RLR acti-
vation and subsequent antiviral responses. We identified the
inhibitory subunit I-1 as a target for the kinase Raf-1. It remains
to be established whether phosphorylation of I-1 occurs either
directly by Raf-1 or via downstream effector(s). We observed
that Raf-1-mediated phosphorylation of I-1 induced its associa-
tion with GADD34-PP1-specific holoenzymes, which blocked
the phosphatase activity of the GADD34-PP1 complexes andell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc. 37
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Figure 7. DC-SIGN-Raf-1 Signaling Induced by MV Promotes Infection of DCs
(A–C) Infection of DCs 24 and 48 hr after infection with rMVKS after silencing of GADD34 (A), I-1 (B), or Raf-1 (C), determined by flow cytometry by measuring the
percentage of EGFP+ cells. Data are presented as mean ± SD of duplicate samples.
(D and E) mRNA expression of IFN-b, MxA (D), and MV-N (E) in lung-resident DC-SIGN+ DCs from cynomolgus macaques 24 hr after infection with rMVKS in the
absence or presence of Raf inhibitor GW5074, measured by real-time PCR, normalized to GAPDH, and set at 1 in MV-infected cells.
Data are representative of at least three (A–C) or one (D and E) independent experiments. See also Figure S1.
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and Mda5 in DCs strongly suppressed type I IFN responses
and allowed efficient replication of MV in DCs. Thus, these find-
ings have identified PP1 phosphatases as targets for antiviral
suppression. DC-SIGN-mediated suppression of RLR activation
is crucial for MV to infect DCs, since Raf-1 inhibition by small
molecule inhibitors or RNAi led to a strong increase of IFN-b
and ISG expression after MV infection, which inhibited viral repli-
cation, underscoring the importance of DC-SIGN-dependent
RLR suppressive mechanism in establishing MV replication in
DCs. DC-SIGN crosslinking with antibodies against DC-SIGN
similarly induced Raf-1 activation and suppressed RLR dephos-
phorylation, strongly suggesting that antibody crosslinking
induces mannose-specific signaling by DC-SIGN (Gringhuis
et al., 2009a) and can be used to investigate the role of mannose
signaling via DC-SIGN in modulation of immune responses.
Further investigation revealed the transient nature of the DC-
SIGN-mediated modulation of RLR signaling. Two pathogenic
MV strains inhibited RLR dephosphorylation early after infectionFigure 6. DC-SIGN-Raf-1 Signaling Inhibits RLR Activation and Type I
(A and C) Overall (A) or GADD34-specific (C) PP1 phosphatase activity in who
crosslinking with isotype or DC-SIGN-specific antibodies (left) or 24 hr after infec
GW5074. Data are presented as mean ± SD.
(B, E, and F) RIG-I phosphorylation at Ser8 or Thr170 and Mda5 phosphoryla
crosslinking with isotype or DC-SIGN-specific antibodies (B and F); or 8 hr after r
(Gb) (B) or after GADD34 or I-1 silencing (E and F), as determined by flow cytom
(D) I-1 phosphorylation at Ser or Thr residues, and association with PP1a or P
unstimulated or 3 hr after infection with rMVKS, in the absence or presence of GW
(G and H) IFN-b, MxA, and ISG15mRNA expression by DCs 8 hr after stimulation w
antibodies (G) or 24 hr after infection with rMVKS (H), after GADD34 or I-1 silenci
poly(I:C)-LV-stimulated control-silenced cells. Data are presented as mean ± SD
Data are representative of at least two (A, D, and F), three (B, E, G, and H), or fo
Cin a Raf-1-dependent manner. Our data strongly suggest that the
Raf-1-dependent suppressive mechanism is the major mecha-
nism early in infection for MV to establish infection of DCs, since
Raf-1 inhibition strongly increased type I IFN responses and
decreased MV infection. Notably, at 16 h.p.i, we observed that
Mda5 remained phosphorylated, whereas RIG-I was dephos-
phorylated. These data suggest that another mechanism later
during infection prevents Mda5, but not RIG-I dephosphoryla-
tion. MV nonstructural P/V/C proteins have been described to
interfere with type I IFN induction, e.g., by interacting with
RLRs or downstream effector molecules in RLR or interferon
signaling pathways (Andrejeva et al., 2004; Palosaari et al.,
2003; Ramachandran and Horvath, 2009; Schuhmann et al.,
2011; Devaux et al., 2013). The MV-V protein is known to specif-
ically bind Mda5 (Andrejeva et al., 2004). In our accompanying
paper, we show that MV-V protein, once synthesized, affects
Mda5 dephosphorylation after MV infection (Davis et al., 2014).
Thus, MV targets DC-SIGN early in infection to inhibit both
RIG-I and Mda5 dephosphorylation, whereas later in infection,IFN Responses via Phosphorylation of GADD34-PP1 Inhibitor I-1
le-cell lysates of DCs 1 hr after stimulation with poly(I:C)-LV and/or receptor
tion with rMVKS or rMVIC323 (right), in the absence or presence of Raf inhibitor
tion at Ser88 in DCs left unstimulated; or 3 hr after stimulation by receptor
MVKS infection (E), in the absence or presence of GADD34 inhibitor guanabenz
etry.
P1g after immunoprecipitation (IP) of I-1 from whole-cell lysates of DCs left
5074, determined by immunoblotting (IB).
ith poly(I:C)-LV and/or receptor crosslinking with isotype or DC-SIGN-specific
ng, measured by real-time PCR, normalized to GAPDH, and set at 1 in MV- or
. *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t test).
ur (C) independent experiments. See also Figure S1.
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during infection (Davis et al., 2014). Because of positive feed-
back in the RLR pathway (Hou et al., 2011), it is tempting to spec-
ulate that DC-SIGN-mediated antiviral suppression, which does
not involve viral replication, is required to suppress both RIG-I
and Mda5 to enable replication initiation in DCs, after which
MV-V protein contributes further to antiviral suppression by
blocking Mda5 activation. These data further indicate that PP1
phosphatases are important targets for MV to control RLRs
and thereby type I IFN responses.
Crosstalk between signaling pathways of different PRRs, such
as DC-SIGN and TLRs, is crucial for induction of pathogen-spe-
cific cytokine profiles (Gringhuis et al., 2007, 2009b). We have
previously shown that activation of Raf-1 via DC-SIGN modu-
lates NF-kB activity, affecting adaptive responses (Gringhuis
et al., 2007). Moreover, we have shown that DC-SIGN-Raf-1
signaling to NF-kB is exploited by HIV-1 for its replication in
DCs (Gringhuis et al., 2010). Here we show that MV requires
Raf-1 signaling to inhibit dephosphorylation of both RIG-I
and Mda5 to escape antiviral responses. Although Raf-1
signaling also induces acetylation of NF-kB (Gringhuis et al.,
2007, 2009b), we did not observe a role for NF-kB acetylation
in the inhibition of type I IFN responses by MV (data not shown).
Raf-1 has a central role in DC-SIGN-mediated suppression of
antiviral responses; we observed both increased RLR activation
and type I IFNexpressionaswell as reduced infectionofDCsafter
Raf-1 inhibition. Raf-1 has been implicated in type I IFN expres-
sion and viral replication previously (Battcock et al., 2006;
Pleschka et al., 2001; Zhanget al., 2012); however, herewe report
a DC-SIGN-dependent effect of the kinase. A role for DC-SIGN
in promotion of MV replication via attachment has been shown
earlier (deWitte et al., 2008;Mesmanet al., 2012).MV thus seems
to target DC-SIGN to promote infection viamultiplemechanisms,
indicating a pivotal role for the receptor in viral infections.
DC-SIGN functions as an attachment receptor for many
viruses, such as HIV-1, hepatitis C virus, and dengue virus (Geij-
tenbeek et al., 2009), and some of these viruses might also use
DC-SIGN to target phosphatases to decrease virus-induced
RLR activation and as such evade antiviral responses (Wies
et al., 2013). Indeed, mannose-expressing viruses that interact
with DC-SIGN induce Raf-1 activation (Gringhuis et al., 2007),
suggesting that PP1 suppression is not restricted to MV. More-
over, since Raf-1 can be activated by other C-type lectin recep-
tors (Gringhuis et al., 2009b), Raf-1 signaling to decrease type I
IFN responses could be a more general evasion strategy, not
limited to DC-SIGN+ DCs, but could also occur in other cells
via other C-type lectin receptors.
These data strongly indicate that PP1 phosphatases are tar-
gets for viruses to evade antiviral immunity, and preventing sup-
pression of phosphatase activity by viruses might be a strategy
to combat viral infections. Our study reveals that MV modulates
antiviral responses at the level of RLR activation by blocking PP1
activity and highlights the role of DC-SIGN in viral infections.EXPERIMENTAL PROCEDURES
Cells and Ethics Statement
Peripheral blood monocytes were isolated from buffy coats of healthy donors
(Sanquin) by consecutive Lymphoprep (Axis-Shield) and Percoll (Amersham40 Cell Host & Microbe 16, 31–42, July 9, 2014 ª2014 Elsevier Inc.Biosciences) gradient steps. Immature monocyte-derived DCs were cultured
for 6–7 days from monocytes, in the presence of IL-4 and GM-CSF (500 and
800 U/ml, respectively; Invitrogen). DCs were cultured in RPMI supplemented
with 10% fetal calf serum, penicillin/streptomycin (10 U/ml and 10 mg/ml,
respectively; Invitrogen), and 2 mM L-glutamine (Lonza).This study was done
in accordance with the ethical guidelines of the Academic Medical Center.
Broncho alveolar lavage (BAL) cells from MV-seronegative cynomolgus
macaques (Macaca fascicularis) had been collected as prevaccination control
samples during a previous study (de Swart et al., 2006) and stored at –135C.
This study was approved by the independent animal experimentation
ethical review committee Dier Experimenten Commissie in Driebergen, the
Netherlands and conducted in compliance with European guidelines (EU
directive on animal testing 86/609/EEC) and Dutch legislation (Experiments
on Animals Act, 1997). DC-SIGN+ DCs were isolated by positive selection
fromBAL cells using the CD209MicroBead Kit (Miltenyi) according to theman-
ufacturer’s instructions. Cells from four different animals were pooled before
experiments.
Cells were stimulated with poly(I:C)-LyoVec (LMW) (1 mg/ml; Invivogen) or
DC-SIGN crosslinking (10 mg/ml goat-anti mouse [Jackson ImmunoResearch
Laboratories] was coated, followed by 20 mg/ml anti-DC-SIGN [AZN-D1; Geij-
tenbeek et al., 2000] or IgG1 isotype control before addition of cells). Cells
were preincubated with inhibitors for 2 hr or blocking antibodies for 30 min
with Raf inhibitor GW5074 (Lackey et al., 2000) (1 mM; Sigma), guanabenz ac-
etate salt (Tsaytler et al., 2011) (5–50 nM; Sigma), anti-DC-SIGN (20 mg/ml;
AZN-D1), or anti-CD150 (20 mg/ml; MCA2251XZ; SBD Serotec). Cells were co-
cultured with Z-D-Phe-Phe-Gly-OH FIP (0.2 mM; Bachem) or recombinant
neutralizing soluble IFNAR (B18R; eBioscience).
DCs were transfected with 25 nM siRNA using transfection reagent DF4
(Dharmacon) as described (Gringhuis et al., 2009b). SMARTpool siRNAs
used were RIG-I (M-012511-01), Mda5 (M-013041-00), TBK1 (M-003788-
02), IKKε (M-003723-02), Raf-1 (M-003601-02), GADD34 (M-004442-01), I-1
(M-017092-01), and nontargeting siRNA (D-001206-13) as a control (Dharma-
con). Silencing of expression was verified by real-time PCR and flow cytometry
(Figures 3 and S1). Raf-1 expression was determined with anti-Raf-1 (9422;
Cell Signaling Technology).
Viruses and Infection Assay
rMVKSEGFP(3) and rMVIC323EGFP(1) (Hashimoto et al., 2002) were passaged
maximally three times in human Epstein-Barr virus-transformed B-lympho-
blastic cell lines (B-LCL) or VERO/hCD150 cells to prevent attenuation. The
titer was determined by titration on VERO/hCD150 cells, and the multiplicity
of infection (moi) of each experiment was calculated based on this titer. DCs
were infected with MV at an moi of 1, unless stated otherwise. Infection was
determined after 24 or 48 hr; cells were fixed in 4% (w/v) paraformaldehyde,
and EGFP levels were determined by flow cytometry.
Quantitative Real-Time PCR
mRNA was isolated using mRNA capture kit (Roche). For detection of MV-N
mRNA, cells were extensively washed before lysis. Detection of MV-N repre-
sents viral replication, as only mRNA, but no viral RNA, is isolated by mRNA
capture kit. cDNA was synthesized with reverse transcriptase kit (Promega).
PCR amplification was performed in the presence of SYBR Green in an ABI
7500 Fast PCR detection system (Applied Biosystems). Expression of target
genes was normalized for GAPDH transcription with Nt = 2
Ct (GAPDH)-Ct (target).
Primers (Table S1) were designed using Primer Express (Applied Biosystems),
except for MV-N primers.
Protein Phosphorylation
Phosphorylation of RIG-I, Mda5, TBK1, IKKε, and Raf-1 was detected by
flow cytometry and analyzed on a FACS Calibur. Cells were first fixed in
3% paraformaldehyde for 10 min and permeabilized in 90% methanol at
4C for 30 min. Primary antibody incubation with phospho-RIG-I(S8)
(PAB15905; Abnova), phospho-RIG-I(T170) (PAB15906; Abnova), phospho-
Mda5(S88) (Wies et al., 2013), phospho-c-raf(Ser338) (9427S; Cell Signaling
Technology), c-raf(pTyr340/341) (553009; Calbiochem), phospho-TBK1/
NAK(Ser172) (5483S; Cell Signaling Technology), and phospho-IKK-epsi-
lon(Ser172) (06-1340; Millipore) was followed by incubation with PE-conju-
gated anti-rabbit (711-116-152; Jackson ImmunoResearch).
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Whole-cell extracts were prepared using RIPA lysis buffer (Cell Signaling Tech-
nology), and proteins were resolved by SDS-PAGE and detected with phos-
pho-RIG-I(S8), phospho-RIG-I(T170), and phospho-Mda5(S88). Membranes
were also probed with anti-b-actin (sc-81178; Santa Cruz) to ensure equal
protein loading. Primary antibody incubation was followed by incubation
with HRP-conjugated secondary antibody (rabbit: 21230, Pierce or mouse:
P0161, DAKO) and ECL detection (Pierce).
IRF3 Cellular Localization
Nuclear and cytoplasmic extracts were prepared using NucBuster protein
extraction kit (Novagen). Proteins were resolved by SDS-PAGE and detected
by immunoblotting with anti-iRF3 (sc-9082; Santa Cruz). Membranes were
also probed with anti-RNAPII (clone CTD4H8; Millipore) or anti-b-actin to
ensure equal protein loading among cytoplasmic and nuclear extracts,
respectively. Detection was done as described above. IRF3 was also detected
by ELISA (USCN Life Sciences).
I-1 Phosphorylation and Association with PP1
I-1 was immunoprecipitated from 40 mg of extract with anti-PP1 inhibitor
(ab40877; Abcam) on protein A/G-PLUS agarose beads (Santa Cruz) before
immunocomplexes were resolved by SDS-PAGE, and phosphorylation of I-1
or I-1-associated PP1 proteins were detected by immunoblotting with anti-
phosphoserine (ab9332; Abcam), anti-phosphothreonine (9381; Cell Signaling
Technology), anti-PP1alpha (2582; Cell Signaling Technology), or anti-
PP1Cgamma (ab169976; Abcam). Detection was done as described above.
PP1 Phosphatase Activity
Whole-cell lysates were prepared using lysis buffer (50 mM HEPES [pH 7.4],
10% glycerol, 1% Triton X-100, supplemented with protease inhibitors). PP1
activity in lysates was measured using ProFluor Ser/Thr PPase assay (Prom-
ega) in the presence of 4 mM okadaic acid to block PP2 activity. GADD34-
PP1 specific activity in lysates was measured after capturing GADD34 in
anti-GADD34 (ab131402; Abcam)-coated black-walled high-binding 96-well
plates. The detected R110 fluorescence is a measure for PP1 activity.
Statistical Analysis
Statistical analyses were performed using the Student’s t test for paired obser-
vations. Statistical significance was set at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.chom.2014.06.008.
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